article thumbnail

Gianluca Pirozzi, MD, PhD, Celebrated for Dedication to the Field of Immunology and Rare Disease Research

The Pharma Data

Dr. Pirozzi received a Doctorate of Medicine from Università Campus Bio-Medico di Roma in Italy, a Doctorate of Philosophy in Immunology from Sapienza Università di Roma in Italy, a Post-Doctorate degree in Immunology from the Institut Pasteur in Paris, France, and business training at the London Business School, UK.

Disease 52
article thumbnail

Targeted protein degradation: turning undruggable targets into druggable targets

Drug Target Review

Dr Yoshitsugu Shitaka is the Chief Scientific Officer (CScO) at Japan-based pharmaceutical company, Astellas Pharma Inc. Masahiko graduated from Nagoya University’s Faculty of Science, holds a doctorate from Tokyo University of Science and touts more than 25 years of pharmaceutical industry experience. 2021;17(1):55–69.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China

The Pharma Data

21, 2020 (GLOBE NEWSWIRE) — Shanghai Haini Pharmaceutical Co., They are one of the top pharmaceutical firms in China and are considered a market leader in the antibiotics space. About YRPG Yangtze River Pharmaceutical Group (YRPG) was founded in 1971, which is headquartered in Taizhou, China.

article thumbnail

Women in Stem with Dr Sara Sangha

Drug Target Review

As a female undergraduate student studying pharmaceutical sciences, one of the biggest challenges was not having enough female leaders as mentors. Since joining Allergan Aesthetics in 2001, my role in medical affairs has always focused, in one way or another, on supporting the journey of a drug/device from bench to bedside.

article thumbnail

Chipscreen and HISUN reach a strategic cooperation

The Pharma Data

(hereinafter referred to as: CHIPSCREEN BIOSCIENCES) and ZHEJIANG HISUN PHARMACEUTICAL CO., hereinafter referred to as: HISUN PHARMACEUTICAL) announced that they have reached a strategic cooperation. SH) was founded in Shenzhen on 2001, specializing in the research and development of novel small molecule drugs.

article thumbnail

What to expect from PEGS Europe 2023: Day 2

Drug Discovery World

Alessa Schaffrath, Doctoral Student, UKE Hamburg, on: ‘Transgenic llama mice – a fast and flexible single domain discovery tool’. Dimitris Skokos, PhD, Senior Director, Cancer Immunology, Regeneron Pharmaceuticals, on: ‘Tumour-targeted costimulation via CD28 bispecific antibodies: Turning immunotherapy “cold” tumours “hot”’.

article thumbnail

Another Update on Medical Abortion Litigation

Drug & Device Law

341 (2001), is so important. Even worse is standing based on the “considerable mental and emotional stress on emergency-room doctors,” purported injury from “divert[ing] time and resources away from their ordinary practice to treat [adverse reaction] patients, and even the possibility of increased malpractice insurance costs.

FDA 52